Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
Appointed director
CC transcript
Tamir Biotechnology, Inc. (ACEL) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/11/2013 8-K Quarterly results
01/15/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
10/19/2012 8-K Entry into a Material Definitive Agreement
06/14/2012 8-K Form 8-K - Current report
03/16/2012 8-K Form 8-K - Current report
01/13/2012 8-K/A Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Memorandum of Understanding on Co-operation between Tamir Biotechnology Inc. and US Pharmacia International Inc"
12/23/2011 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/15/2011 8-K Entry into a Material Definitive Agreement
02/11/2011 8-K Form 8-K - Current report
10/01/2010 8-K Form 8-K - Current report
04/30/2010 8-K Form 8-K - Current report
04/27/2010 8-K Investor presentation
Docs: "Copy of presentation materials of Alfacell Corporation disclosed on April 27, 2010"
03/04/2010 8-K Form 8-K - Current report
02/10/2010 8-K Other Events
02/04/2010 8-K Form 8-K - Current report
10/20/2009 8-K Form 8-K - Current report
09/15/2009 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement
04/06/2009 8-K Form 8-K - Current report
03/11/2009 8-K Form 8-K -- Current report
02/23/2009 8-K Form 8-K -- Current report
01/06/2009 8-K Form 8-K -- Current report
12/16/2008 8-K Quarterly results
Docs: "PRESS RELEASE OF ALFACELL CORPORATION DATED DECEMBER 10, 2008.",
"PRESS RELEASE OF ALFACELL CORPORATION DATED DECEMBER 12, 2008."
10/17/2008 8-K Quarterly results
Docs: "Alfacell Reports Fiscal Fourth Quarter and Full Year 2008 Financial Results"
10/03/2008 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
08/01/2008 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
Docs: "Alfacell Receives NASDAQ Delisting Letter"
07/18/2008 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
Docs: "Alfacell Receives NASDAQ Non-Compliance Notification"
06/26/2008 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
Docs: "Alfacell Receives NASDAQ Non-Compliance Notification SOMERSET, N.J., June 26, 2008 -"
06/09/2008 8-K Quarterly results
Docs: "Alfacell Reports Financial Results for Third Quarter of Fiscal 2008"
05/28/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "Alfacell Corporation Announces Preliminary Results from ONCONASE ® Phase IIIb Clinical Trial"
04/28/2008 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Departure of Directors or Princip...
Docs: "Retirement Agreement by and between Alfacell Corporation and Kuslima Shogen",
"Investor Contact:"
04/08/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "Alfacell Updates Status of ONCONASE ® Phase III Clinical Program"
03/11/2008 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
03/07/2008 8-K Quarterly results
Docs: "Alfacell Reports Financial Results for Second Quarter of Fiscal 2008"
01/30/2008 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Copy of presentation materials of Alfacell Corporation disclosed on January 30, 2008",
"Alfacell Updates Status of ONCONASE ® Phase III Clinical Program"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy